Dietary and enteral interventions for Crohn's disease

Current Opinion in Biotechnology

Volumn 44, Issue , 2017, Pages 69-73

  Yamamoto, Takayuki ^a   Shimoyama, Takahiro ^a   Kuriyama, Moeko ^a  

^a Yokkaichi Hazu Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CARBOHYDRATES; DISEASE CONTROL; FATTY ACIDS; NUTRITION; POLYUNSATURATED FATTY ACIDS;

CRITICAL ASSESSMENT; CROHN'S DISEASE; ENTERAL NUTRITION; GASTROINTESTINAL SYMPTOMS; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY RESPONSE; OMEGA-3 POLYUNSATURATED FATTY ACIDS; PREDISPOSING FACTORS;

DISEASES;

GLUTAMINE; OMEGA 3 FATTY ACID; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

BACTERIAL FLORA; CROHN DISEASE; DIET THERAPY; DIETARY INTAKE; DISEASE PREDISPOSITION; DOWN REGULATION; DRUG EFFICACY; ENTERIC FEEDING; GASTROINTESTINAL SYMPTOM; GENETIC PREDISPOSITION; HUMAN; IMMUNE DYSREGULATION; IMMUNOPATHOGENESIS; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; LOW CARBOHYDRATE DIET; MAINTENANCE THERAPY; META ANALYSIS; NUTRITIONAL STATUS; PRIORITY JOURNAL; REVIEW; DIET;

CROHN DISEASE; DIET; ENTERAL NUTRITION; FATTY ACIDS, OMEGA-3; HUMANS; PREBIOTICS; PROBIOTICS;

EID: 85002534262     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2016.11.011     Document Type: Review

References (46)

1. 1 Sarbagili-Shabat, C., Sigall-Boneh, R., Levine, A., Nutritional therapy in inflammatory bowel disease. Curr Opin Gastroenterol 31 (2015), 303–308.
2. 2 Michielan, A., D'Incà, R., Intestinal permeability in inflammatory bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut. Mediators Inflamm, 2015, 2015, 628157.
3. 3• Matijašić, M., Meštrović, T., Perić, M., Čipčić Paljetak, H., Panek, M., Vranešić Bender, D., Ljubas Kelečić, D., Krznarić Ž, Verbanac, D., Modulating composition and metabolic activity of the gut microbiota in IBD patients. Int J Mol Sci, 17, 2016, 578 This review presented currently available and emerging therapeutic options in modulating composition and metabolic activity of gut microbiota in patients with inflammatory bowel disease.
4. 4 Lorente-Cebrián, S., Costa, A.G., Navas-Carretero, S., Zabala, M., Laiglesia, L.M., Martínez, J.A., Moreno-Aliaga, M.J., An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases. J Physiol Biochem 71 (2015), 341–349.
5. 5 Andrade, M.E., Araújo, R.S., de Barros, P.A., Soares, A.D., Abrantes, F.A., Generoso, S.V., Fernandes, S.O., Cardoso, V.N., The role of immunomodulators on intestinal barrier homeostasis in experimental models. Clin Nutr 34 (2015), 1080–1087.
6. 6 Marini, J.C., Interrelationships between glutamine and citrulline metabolism. Curr Opin Clin Nutr Metab Care 19 (2016), 62–66.
7. 7 Yamamoto, T., Nakahigashi, M., Saniabadi, A.R., Review article: diet and inflammatory bowel disease — epidemiology and treatment. Aliment Pharmacol Ther 30 (2009), 99–112.
8. 8 Yamamoto, T., Nutrition and diet in inflammatory bowel disease. Curr Opin Gastroenterol 29 (2013), 216–221.
9. 9•• Lichtenstein, L., Avni-Biron, I., Ben-Bassat, O., Probiotics and prebiotics in Crohn's disease therapies. Best Pract Res Clin Gastroenterol 30 (2016), 81–88 This study showed evidence available on the clinical effects of probiotics and prebiotics in Crohn's disease and clarified the place of probiotic treatment in current therapeutic regimens.
10. 10 Schultz, M., Timmer, A., Herfarth, H.H., Sartor, R.B., Vanderhoof, J.A., Rath, H.C., Lactobacillus GG in inducing and maintaining remission of Crohn's disease. BMC Gastroenterol, 4, 2004, 5.
11. 11 Schultz, M., Linde, H.J., Lehn, N., Zimmermann, K., Grossmann, J., Falk, W., Schölmerich, J., Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers. J Dairy Res 70 (2003), 165–173.
12. 12 Fujiya, M., Ueno, N., Kohgo, Y., Probiotic treatments for induction and maintenance of remission in inflammatory bowel diseases: a meta-analysis of randomized controlled trials. Clin J Gastroenterol 7 (2014), 1–13.
13. 13 Shen, J., Zuo, Z.X., Mao, A.P., Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm Bowel Dis 20 (2014), 21–35.
14. 14 Ghouri, Y.A., Richards, D.M., Rahimi, E.F., Krill, J.T., Jelinek, K.A., DuPont, A.W., Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. Clin Exp Gastroenterol 7 (2014), 473–487.
15. 15 Butterworth, A.D., Thomas, A.G., Akobeng, A.K., Probiotics for induction of remission in Crohn's disease. Cochrane Database Syst Rev, 3, 2008, CD006634.
16. 16 Rolfe, V.E., Fortun, P.J., Hawkey, C.J., Bath-Hextall, F., Probiotics for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev, 4, 2006, CD004826.
17. 17 Roberfroid, M., Prebiotics: the concept revisited. J Nutr 137:Suppl. 2 (2007), 830S–837S.
18. 18 Scott, K.P., Martin, J.C., Duncan, S.H., Flint, H.J., Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro. FEMS Microbiol Ecol 87 (2014), 30–40.
19. 19 Lindsay, J.O., Whelan, K., Stagg, A.J., Gobin, P., Al-Hassi, H.O., Rayment, N., Kamm, M.A., Knight, S.C., Forbes, A., Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut 55 (2006), 348–355.
20. 20 Hafer, A., Krämer, S., Duncker, S., Krüger, M., Manns, M.P., Bischoff, S.C., Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study. BMC Gastroenterol, 7, 2007, 36.
21. 21 Joossens, M., De Preter, V., Ballet, V., Verbeke, K., Rutgeerts, P., Vermeire, S., Effect of oligofructose-enriched inulin (OF-IN) on bacterial composition and disease activity of patients with Crohn's disease: results from a double-blinded randomised controlled trial. Gut, 61, 2012, 958.
22. 22 Benjamin, J.L., Hedin, C.R., Koutsoumpas, A., Ng, S.C., McCarthy, N.E., Hart, A.L., Kamm, M.A., Sanderson, J.D., Knight, S.C., Forbes, A., et al. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Gut 60 (2011), 923–929.
23. 23 Shah, S., Dietary factors in the modulation of inflammatory bowel disease activity. MedGenMed, 9, 2007, 60.
24. 24• Obih, C., Wahbeh, G., Lee, D., Braly, K., Giefer, M., Shaffer, M.L., Nielson, H., Suskind, D.L., Specific carbohydrate diet for pediatric inflammatory bowel disease in clinical practice within an academic IBD center. Nutrition 32 (2016), 418–425 This study provides evidence that the specific carbohydrate diet may improve clinical and laboratory parameters for pediatric patients with inflammatory bowel disease.
25. 25• Lev-Tzion, R., Griffiths, A.M., Leder, O., Turner, D., Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev, 2, 2014, CD006320 This study systematically reviewed the efficacy of omega 3 fatty acids for maintenance of remission in Crohn's disease and found that they are probably ineffective.
26. 26 Feagan, B.G., Sandborn, W.J., Mittmann, U., Bar-Meir, S., D'Haens, G., Bradette, M., Cohen, A., Dallaire, C., Ponich, T.P., McDonald, J.W., et al. Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials. JAMA 299 (2008), 1690–1697.
27. 27 Akobeng, A.K., Miller, V., Stanton, J., Elbadri, A.M., Thomas, A.G., Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr 30 (2000), 78–84.
28. 28 Ockenga, J., Borchert, K., Stüber, E., Lochs, H., Manns, M.P., Bischoff, S.C., Glutamine-enriched total parenteral nutrition in patients with inflammatory bowel disease. Eur J Clin Nutr 59 (2005), 1302–1309.
29. 29• Akobeng, A.K., Elawad, M., Gordon, M., Glutamine for induction of remission in Crohn's disease. Cochrane Database Syst Rev, 2, 2016, CD007348 This study evaluated the efficacy of glutamine supplementation for induction of remission in Crohn's disease and found that it may not be beneficial.
30. 30 Zachos, M., Tondeur, M., Griffiths, A.M., Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev, 1, 2007, CD000542.
31. 31 Dziechciarz, P., Horvath, A., Shamir, R., Szajewska, H., Meta-analysis: enteral nutrition in active Crohn's disease in children. Aliment Pharmacol Ther 26 (2007), 795–806.
32. 32 Modigliani, R., Mary, J.Y., Simon, J.F., Cortot, A., Soule, J.C., Gendre, J.P., Rene, E., Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives. Gastroenterology 98 (1990), 811–818.
33. 33 Yamamoto, T., Nakahigashi, M., Umegae, S., Kitagawa, T., Matsumoto, K., Impact of elemental diet on mucosal inflammation in patients with active Crohn's disease: cytokine production and endoscopic and histological findings. Inflamm Bowel Dis 11 (2005), 580–588.
34. 34 Borrelli, O., Cordischi, L., Cirulli, M., Paganelli, M., Labalestra, V., Uccini, S., Russo, P.M., Cucchiara, S., Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol 4 (2006), 744–753.
35. 35 Berni Canani, R., Terrin, G., Borrelli, O., Romano, M.T., Manguso, F., Coruzzo, A., D'Armiento, F., Romeo, E.F., Cucchiara, S., Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease. Dig Liver Dis 38 (2006), 381–387.
36. 36 Verma, S., Kirkwood, B., Brown, S., Giaffer, M.H., Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease. Dig Liver Dis 32 (2000), 769–774.
37. 37 Verma, S., Holdsworth, C.D., Giaffer, M.H., Does adjuvant nutritional support diminish steroid dependency in Crohn disease?. Scand J Gastroenterol 36 (2001), 383–388.
38. 38 Takagi, S., Utsunomiya, K., Kuriyama, S., Yokoyama, H., Takahashi, S., Iwabuchi, M., Takahashi, H., Takahashi, S., Kinouchi, Y., Hiwatashi, N., et al. Effectiveness of an ‘half elemental diet’ as maintenance therapy for Crohn's disease: a randomized-controlled trial. Aliment Pharmacol Ther 24 (2006), 1333–1340.
39. 39 Yamamoto, T., Nakahigashi, M., Saniabadi, A.R., Iwata, T., Maruyama, Y., Umegae, S., Matsumoto, K., Impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn's disease: a prospective study. Inflamm Bowel Dis 13 (2007), 1493–1501.
40. 40 Yamamoto, T., Nakahigashi, M., Umegae, S., Kitagawa, T., Matsumoto, K., Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: a prospective, non-randomized, parallel, controlled study. Aliment Pharmacol Ther 25 (2007), 67–72.
41. 41 Yamamoto, T., Nakahigashi, M., Umegae, S., Matsumoto, K., Prospective clinical trial: enteral nutrition during maintenance infliximab in Crohn's disease. J Gastroenterol 45 (2010), 24–29.
42. 42 Hanai, H., Iida, T., Takeuchi, K., Arai, H., Arai, O., Abe, J., Tanaka, T., Maruyama, Y., Ikeya, K., Sugimoto, K., et al. Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease. Dig Liver Dis 44 (2012), 649–654.
43. 43 Yamamoto, T., Shiraki, M., Nakahigashi, M., Umegae, S., Matsumoto, K., Enteral nutrition to suppress postoperative Crohn's disease recurrence: a five-year prospective cohort study. Int J Colorectal Dis 28 (2013), 335–340.
44. 44• Nakahigashi, M., Yamamoto, T., Sacco, R., Hanai, H., Kobayashi, F., Enteral nutrition for maintaining remission in patients with quiescent Crohn's disease: current status and future perspectives. Int J Colorectal Dis 31 (2016), 1–7 This study thoroughly reviewed the clinical trials evaluating the efficacy of enteral nutrition for quiescent Crohn's disease and found that enteral nutrition may be useful as maintenance therapy.
45. 45 Akobeng, A.K., Thomas, A.G., Enteral nutrition for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev, 3, 2007, CD005984.
46. 46 Yamamoto, T., Nakahigashi, M., Umegae, S., Matsumoto, K., Enteral nutrition for the maintenance of remission in Crohn's disease: a systematic review. Eur J Gastroenterol Hepatol 22 (2010), 1–8.